首页> 外国专利> Double composite tablet for oral administration including tramadol and celecoxib

Double composite tablet for oral administration including tramadol and celecoxib

机译:用于口服的双重复合片剂,包括曲马多和塞来昔布

摘要

The present invention is to alleviate the symptoms or signs of osteoarthritis (degenerative arthritis), alleviate the symptoms and signs of rheumatoid arthritis, alleviate the symptoms and signs of ankylosing spondylitis, acute pain relief (after surgery, pain after extraction), primary dysmenorrhea, An oral preparation prescribed for severe and moderate acute pain, comprising: a sustained release layer containing tramadol as an active ingredient; And it relates to a dual complex tablet for oral administration comprising a rapid release layer containing celecoxib as an active ingredient. Through the present invention, it is possible to provide a composition for treating pain having a sustained analgesic effect for 12 hours while reducing the side effects of tramadol by releasing the water-soluble tramadol and releasing the poorly soluble celecoxib. By preparing a combination product, the number of medications can be reduced to increase the convenience of taking.
机译:本发明旨在减轻骨关节炎(退化性关节炎)的症状或体征,减轻类风湿性关节炎的症状和体征,减轻强直性脊柱炎的症状和体征,急性疼痛缓解(手术后,拔除后的疼痛),原发性痛经,用于严重和中度急性疼痛的口服制剂,其包含:含有曲马多作为活性成分的缓释层;和本发明涉及一种口服复合双重片剂,其包含含有塞来昔布作为活性成分的快速释放层。通过本发明,可以提供通过释放水溶性曲马多并释放难溶性塞来昔布来减轻疼痛的药物组合物,该组合物具有持续的镇痛作用12小时,同时减少了曲马多的副作用。通过制备组合产品,可以减少药物数量以增​​加服用的便利性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号